Remove Circulation Remove Heart Attack Remove Risk Factors
article thumbnail

Why Waiting Until Age 50 To Address Risk Factors For Heart Disease Is Too Late.

Dr. Paddy Barrett

When you look at the risk of having a heart attack, it is true that the older you are, the greater the odds of having a heart attack 1. While only 1-2% of those having a heart attack are less than 65 years of age, 1-2% of this very large number means a LOT of heart attacks.

article thumbnail

Trial Results: Low-Dose Colchicine HelpsTreat Cardiovascular Disease

DAIC

mg tablet), ananti-inflammatory atheroprotective cardiovascular treatment, to reduce the risk of myocardial infarction (MI), stroke, coronary revascularization, and cardiovascular death in adult patients with established atherosclerotic disease or with multiple risk factors for cardiovascular disease.

article thumbnail

You Have High Cholesterol & Don't Know What To Do About It.

Dr. Paddy Barrett

The Consequences of High Cholesterol Why high cholesterol is more than just a number—it’s a major risk factor for heart disease and stroke. Understanding How Cholesterol Changes Your Risk of a Heart Attack How to assess whether high cholesterol has significantly increased your risk.

article thumbnail

How To Show Your Heart Some Love This February

AMS Cardiology

Understand the warning signs and symptoms of heart attacks. Some heart attacks are very sudden and intense, leaving little time to respond to signs or symptoms. Other heart attacks, however, start slowly with mild pain or discomfort. Know your family heart health history.

article thumbnail

Why Measuring ApoB Is The Key To Preventing Heart Disease.

Dr. Paddy Barrett

Therefore, the number of ApoB particles is a direct measure of the number of circulating cholesterol particles in your bloodstream. No heart attacks. As the number of ApoB particles increases, the risk of atherosclerosis increases. When both LDL-C and ApoB are at low levels, that increased risk disappears.

article thumbnail

Lowering Atherosclerotic Cardiovascular Disease Events by Treating Residual Inflammatory Risk

DAIC

3 Patients with ASCVD are at a higher risk for major adverse cardiovascular events (MACE) including heart attack or myocardial infarction (MI), stroke, and cardiovascular (CV) death.4 21 Luckily, each of these risks can be measured by simple blood tests. 4 In the U.S.

article thumbnail

Agepha Pharma and Caristo Diagnostics Team Up to Fight Coronary Inflammation

DAIC

They will also selectively support clinical research involving the CaRi-Heart technology for coronary inflammation diagnostics and LODOCO 0.5 Caristo shares Agepha Pharma’s passion for fighting coronary inflammation, which is one of the primary drivers of heart attack risks,” said Frank Cheng , CEO of Caristo Diagnostics. “We